Serum-derived factor inducing cell differentiation and medical uses thereof
Patent Number: 6372262
Date of First Priority Issue: Tuesday December 10th, 1996
Date Issued: Tuesday April 16th, 2002
Assignee: Hadasit Medical Research Services & Development Company Ltd. (Jerusalem, IL)
Inventors: Peled, Tony (Mevaseret, IL); Fibach, Eitan (Mevaseret Zion, IL); Rachmilewitz, Eliezer A. (Jerusalem, IL)
From Class: Differentiation
Comments: No comments
This patent covers a factor derived from serum by chemical purification techniques that induces stem cell differentiation, and is able to induce differentiation of leukemic cells.
Such factors have great possibilities in cancer therapy. Older work by Laurence Burton at the Immune Augmentative Therapy (IAT) clinic actually clinically used such factors with good results in mesothelioma patients. Since mesothelioma is associated with asbestos and is a major cancer without clinically significant therapy, the work of Burton should be re-evaluated in light of this patent.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.